BiotechTube
Home/Xcovery/Lieming Ding, M.D.
LD

Lieming Ding, M.D.

Director, Chairman of the Board

Xcovery

Therapeutic Areas

Oncology

Xcovery Pipeline

DrugIndicationPhase
Ensartinib (Ensacove™)ALK-positive Non-Small Cell Lung Cancer (NSCLC)Approved
VorolanibVarious cancers (as monotherapy and combination with IO)Phase 2/3

Leadership Team at Xcovery

GS
Giovanni Selvaggi, M.D.
Director
BL
Bo Li, Ph.D.
Director
View full Xcovery profile